留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

应中央军委要求,2022年9月起,《药学实践杂志》将更名为《药学实践与服务》,双月刊,正文96页;2023年1月起,拟出版月刊,正文64页,数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿!

基于疾病动物模型的中药药动学研究进展

王韵 柴逸峰 朱臻宇

王韵, 柴逸峰, 朱臻宇. 基于疾病动物模型的中药药动学研究进展[J]. 药学实践与服务, 2017, 35(2): 108-111,140. doi: 10.3969/j.issn.1006-0111.2017.02.003
引用本文: 王韵, 柴逸峰, 朱臻宇. 基于疾病动物模型的中药药动学研究进展[J]. 药学实践与服务, 2017, 35(2): 108-111,140. doi: 10.3969/j.issn.1006-0111.2017.02.003
WANG Yun, CHAI Yifeng, ZHU Zhenyu. Advances on pharmacokinetics of traditional Chinese medicine based on animal model under diseased states[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(2): 108-111,140. doi: 10.3969/j.issn.1006-0111.2017.02.003
Citation: WANG Yun, CHAI Yifeng, ZHU Zhenyu. Advances on pharmacokinetics of traditional Chinese medicine based on animal model under diseased states[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(2): 108-111,140. doi: 10.3969/j.issn.1006-0111.2017.02.003

基于疾病动物模型的中药药动学研究进展

doi: 10.3969/j.issn.1006-0111.2017.02.003
基金项目: 国家自然科学基金资助项目(81273472, 81573396)

Advances on pharmacokinetics of traditional Chinese medicine based on animal model under diseased states

  • 摘要: 中药药动学是中药现代化研究必不可少的环节,是中医药与世界接轨的重要手段。药物在作用部位只有达到足够浓度,才能在体内发挥药效,而药物浓度不仅与给药剂量有关,亦受到药物体内过程的影响。传统中药药动学研究多基于健康实验动物展开,忽视了疾病状态下生理和病理变化可能引起相关药动学参数显著改变。本文系统综述了近年来基于常见疾病动物模型开展的中药药动学比较研究,并对不同动物模型药动学比较的研究发展趋势进行讨论和展望。
  • [1] 郭涛. 新编药物动力学[M]. 北京:中国科学技术出版社,2005:338.
    [2] Xu B, Li P, Zhang G. Comparative pharmacokinetics of puerarin, daidzin, baicalin, glycyrrhizic acid, liquiritin, berberine, palmatine and jateorhizine by liquid chromatography-mass spectrometry after oral administration of Gegenqinlian decoction and active components alignment (ACA) to rats[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2015, 988:33-44.
    [3] Chen Y, Li Y, Wang Y, et al. Comparative pharmacokinetics of active alkaloids after oral administration of Rhizoma Coptidis extract and Wuji Wan formulas in rat using a UPLC-MS/MS method[J]. Eur J Drug Metab Pharmacokinet, 2015, 40(1):67-74.
    [4] Liu Y, Wang D, Yang G, et al. Comparative pharmacokinetics and brain distribution of magnolol and honokiol after oral administration of Magnolia officinalis cortex extract and its compatibility with other herbal medicines in Zhi-Zi-Hou-Po Decoction to rats[J]. Biomed Chromatogr:BMC, 2015, 30(3):369-375.
    [5] Xie JT, Wang A, Mehendale S, et al. Anti-diabetic effects of Gymnema yunnanense extract[J]. Pharmacol Res, 2003, 47(4):323-329.
    [6] Feng Y, Liu Z, Peng Y, et al. Validated LC-MS method for simultaneous quantitation of catalpol and harpagide in rat plasma:application to a comparative pharmacokinetic study in normal and diabetic rats after oral administration of Zeng-Ye-Decoction[J]. Biomed Chromatogr:BMC, 2013, 27(11):1503-1510.
    [7] He LH, Li J, Deng YX, et al. Comparative investigation on the pharmacokinetics of geniposide in type 2 diabetic and normal rats after oral administration of Fructus Gradeniae extract[J]. J Chromatogr B Analyt Technol BiomedLife Sci, 2016, 1033:180-186.
    [8] 袁铭兰,田玉芳, 孙晨. 苦荞提取物中槲皮素在糖尿病大鼠体内的药动学研究[J]. 中华灾害救援医学, 2015, 3(8):445-449.
    [9] 范惠霞,邓志鹏,王福文,等. 刺五加注射液在正常大鼠与脑缺血-再灌注损伤疾病大鼠体内药动学比较[J]. 中成药, 2015, 37(6):1215-1221.
    [10] 邵明晶,冯芳. 蒽醌在正常及酒精肝损伤大鼠的药动学比较[J]. 广州化工, 2015, 43(6):53-56.
    [11] Yang T, Liu S, Wang CH, et al. Comparative pharmacokinetic and tissue distribution profiles of four major bioactive components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe[J]. J Pharm Biomed Anal, 2015, 114:152-158.
    [12] Yang T, Liu S, Zheng TH, et al. Comparative pharmacokinetics and tissue distribution profiles of lignan components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe[J]. J Ethnopharmacol, 2015, 166:305-312.
    [13] Zhu H, Bi K, Han F, et al. Simultaneous determination of two iridoid glycosides, two anthraquinones and four flavonoid glycosides of Zhi-Zi-Da-Huang decoction in rat plasma by UFLC-MS/MS:application to a comparative pharmacokinetic study in normal and cholestatic liver injury rats[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2014, 960:116-125.
    [14] Liu R, Ma R, Yu C, et al. Quantitation of eleven active compounds of Aidi injection in rat plasma and its application to comparative pharmacokinetic study[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2016, 1026:105-113.
    [15] Chen J, Chen Z, Ma L, et al. Development of determination of four analytes of Zhi-Shao-San decoction using LC-MS/MS and its application to comparative pharmacokinetics in normal and irritable bowel syndrome rat plasma[J]. Biomed Chromatogr:BMC, 2014, 28(10):1384-1392.
    [16] Zhao M, Qian D, Shang E X, et al. Comparative pharmacokinetics of the main compounds of Shanzhuyu extract after oral administration in normal and chronic kidney disease rats[J]. J Ethnopharmacol, 2015, 173:280-286.
    [17] Zhao M, Qian D, Liu P, et al. Comparative pharmacokinetics of catalpol and acteoside in normal and chronic kidney disease rats after oral administration of Rehmannia glutinosa extract[J]. Biomed Chromatogr:BMC, 2015, 29(12):1842-1848.
    [18] He W, Liu G, Cai H, et al. Integrated pharmacokinetics of five protoberberine-type alkaloids in normal and insomnic rats after single and multiple oral administration of Jiao-Tai-Wan[J]. J Ethnopharmacol, 2014, 154(3):635-644.
    [19] Zhao X, Ma T, Zhang C, et al. Simultaneous determination of senkyunolide I and senkyunolide H in rat plasma by LC-MS:application to a comparative pharmacokinetic study in normal and migrainous rats after oral administration of Chuanxiong Rhizoma extract[J]. Biomed Chromatogr:BMC, 2015, 29(9):1297-1303.
    [20] Wang YH, Hong YL, Feng Y, et al. Comparative pharmacokinetics of senkyunolide I in a rat model of migraine versus normal controls[J]. Eur J Drug Metab Pharmacokinet, 2012, 37(2):91-97.
    [21] 朱黎霞,张英丰. 基于微透析技术结合液质联用的丹酚酸B正常和高脂血症大鼠药动学比较研究[J]. 中草药, 2015, 46(1):90-96.
    [22] 冯彬彬,张建海,牛小花,等. 川芎嗪、阿魏酸和延胡索乙素在模型与正常大鼠体内药动学比较研究[J]. 中草药, 2015, 46(10):1493-1497.
    [23] Wu Y, Ai Y, Wang F, et al. Simultaneous determination of four secoiridoid and iridoid glycosides in rat plasma by ultra performance liquid chromatography-tandem mass spectrometry and its application to a comparative pharmacokinetic study[J]. Biomed chromatogr:BMC, 2015, 30(2):97-104.
    [24] Wu Y, Wang F, Ai Y, et al. Simultaneous determination of seven coumarins by UPLC-MS/MS:Application to a comparative pharmacokinetic study in normal and arthritic rats after oral administration of Huo Luo Xiao Ling Dan or single-herb extract[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2015, 991:108-117.
    [25] 姜丽,高萌,屈飞,等. 基于HPLC-MS/MS研究麻杏石甘汤在正常及RSV肺炎感染模型大鼠体内的药动学[J]. 中国中药杂志, 2015, 40(13):2649-2655.
    [26] Gong XH, Li Y, Zhang RQ, et al. The synergism mechanism of Rhubarb Anthraquinones on constipation elucidated by comparative pharmacokinetics of Rhubarb extract between normal and diseased rats[J]. Eur J DrugMetab Pharmacokinet, 2015, 40(4):379-388.
    [27] 孟祥乐,李红伟,韩永龙,等. 栀子-连翘药对大鼠体内药动学变化特征研究[J]. 中国新药杂志, 2015, 24(17):2003-2009,2024.
    [28] Zeng XY, Dong S, He NN, et al. Comparative pharmacokinetics of arctigenin in normal and type 2 diabetic rats after oral and intravenous administration[J]. Fitoterapia, 2015, 105:119-126.
  • [1] 胡文君, 王品, 郑斯莉, 汪东昇, 缪朝玉.  小鼠心梗模型的建立与早期心电图评价 . 药学实践与服务, 2020, 38(2): 115-119. doi: 10.3969/j.issn.1006-0111.202001011
    [2] 尹萍, 路璐, 陈媛媛, 李丽, 李赟, 童国庆.  来曲唑联合45%高脂饲料诱导生殖内分泌及代谢表型异常的多囊卵巢综合征大鼠模型研究 . 药学实践与服务, 2019, 37(5): 422-426. doi: 10.3969/j.issn.1006-0111.2019.05.007
    [3] 何晓波, 朱佳慧, 高方圆.  生物技术药物药代动力学研究进展 . 药学实践与服务, 2019, 37(5): 394-399. doi: 10.3969/j.issn.1006-0111.2019.05.003
    [4] 吴岚, 蔡同凯, 张立超, 姜远英, 曹永兵.  系统性红斑狼疮动物模型及其发病机制研究进展 . 药学实践与服务, 2018, 36(6): 481-483,492. doi: 10.3969/j.issn.1006-0111.2018.06.001
    [5] 杨波, 纪宏宇, 郑东友, 车丽丽, 吴琳华.  基于疾病动物模型的中药药动学研究进展 . 药学实践与服务, 2017, 35(2): 112-115,153. doi: 10.3969/j.issn.1006-0111.2017.02.004
    [6] 魏纯纯, 王培, 缪朝玉.  脑出血损伤的动物模型及治疗策略的研究进展 . 药学实践与服务, 2016, 34(4): 297-300,376. doi: 10.3969/j.issn.1006-0111.2016.04.003
    [7] 郭凯欣, 石宽, 闻俊, 周婷婷, 范国荣.  唑类抗真菌药物手性分离及药代动力学研究进展 . 药学实践与服务, 2012, 30(6): 418-421. doi: 10.3969/j.issn.1006-0111.2012.06.006
    [8] 姚亚敏, 沐俊, 孙骥, 马芳, 卢洪洲, 张丽军.  洛匹那韦药代动力学的研究进展 . 药学实践与服务, 2012, 30(5): 336-339. doi: 10.3969/j.issn.1006-0111.2012.05.005
    [9] 高守红, 温燕, 邬蓉, 金晓玲, 恽芸蕾, 李静娴, 缪海均.  注射用盐酸米诺环素在健康人体的药物动力学 . 药学实践与服务, 2009, 27(3): 193-194,200.
    [10] 汪涛, 孙亮, 梁蓉梅, 宓鹤鸣.  中药超微粉碎的研究进展与应用前景 . 药学实践与服务, 2007, (3): 129-133.
    [11] 王佩贤, 曹永孝, 杨孝江, 姚鸿萍, 王秀芹.  注射用复方氨苄西林钠药代动力学研究 . 药学实践与服务, 2007, (1): 18-20,30.
    [12] 樊蓉, 张纯, 高申.  蛋白多肽类药物的药代动力学研究概况 . 药学实践与服务, 2006, (3): 135-138.
    [13] 刘新宇, 吴芳.  头孢丙烯在下呼吸道细菌感染患者的药代动力学研究 . 药学实践与服务, 2006, (3): 144-146.
    [14] 江力宣, 闫海英, 阳盛洪, 邱旭民.  药代动力学研究在新药研发中的应用 . 药学实践与服务, 2006, (5): 260-263,288.
    [15] 吕竹芬, 谢清春, 陈燕忠, 申楼, 周松.  西替伪麻缓释片中盐酸伪麻黄碱的动物药代动力学研究 . 药学实践与服务, 2006, (6): 342-345.
    [16] 王少明, 林才经, 杨春波, 施作霖, 庄捷, 阮君山.  大鼠胃粘膜癌前病变实验动物模型的建立 . 药学实践与服务, 2005, (5): 271-272,281.
    [17] 陆文铨, 罗新庚, 朱文娟.  复方新诺明和甲氧等氨嘧啶对丁胺卡那霉素药代动力学的影响 . 药学实践与服务, 1997, (5): 259-264.
    [18] 尹玉琴, 陈振德, 蒋世新.  布美他尼与地高辛相互作用及药代动力学考察 . 药学实践与服务, 1997, (4): 224-225.
    [19] 丁惠萍, 黄平.  抗肿瘤药物的药代动力学及血浓度测定 . 药学实践与服务, 1996, (1): 37-40.
    [20] 王睿, 孙效东, 段云鹏, 包尔宁, 陆茵.  哌拉西林在胆道手术患者中的药代动力学研究 . 药学实践与服务, 1994, (3): 5-10.
  • 加载中
计量
  • 文章访问数:  2262
  • HTML全文浏览量:  186
  • PDF下载量:  405
  • 被引次数: 0
出版历程
  • 收稿日期:  2016-12-05
  • 修回日期:  2016-12-27

基于疾病动物模型的中药药动学研究进展

doi: 10.3969/j.issn.1006-0111.2017.02.003
    基金项目:  国家自然科学基金资助项目(81273472, 81573396)

摘要: 中药药动学是中药现代化研究必不可少的环节,是中医药与世界接轨的重要手段。药物在作用部位只有达到足够浓度,才能在体内发挥药效,而药物浓度不仅与给药剂量有关,亦受到药物体内过程的影响。传统中药药动学研究多基于健康实验动物展开,忽视了疾病状态下生理和病理变化可能引起相关药动学参数显著改变。本文系统综述了近年来基于常见疾病动物模型开展的中药药动学比较研究,并对不同动物模型药动学比较的研究发展趋势进行讨论和展望。

English Abstract

王韵, 柴逸峰, 朱臻宇. 基于疾病动物模型的中药药动学研究进展[J]. 药学实践与服务, 2017, 35(2): 108-111,140. doi: 10.3969/j.issn.1006-0111.2017.02.003
引用本文: 王韵, 柴逸峰, 朱臻宇. 基于疾病动物模型的中药药动学研究进展[J]. 药学实践与服务, 2017, 35(2): 108-111,140. doi: 10.3969/j.issn.1006-0111.2017.02.003
WANG Yun, CHAI Yifeng, ZHU Zhenyu. Advances on pharmacokinetics of traditional Chinese medicine based on animal model under diseased states[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(2): 108-111,140. doi: 10.3969/j.issn.1006-0111.2017.02.003
Citation: WANG Yun, CHAI Yifeng, ZHU Zhenyu. Advances on pharmacokinetics of traditional Chinese medicine based on animal model under diseased states[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(2): 108-111,140. doi: 10.3969/j.issn.1006-0111.2017.02.003
参考文献 (28)

目录

    /

    返回文章
    返回